Recent articles, interviews or news items involving the firm or its attorneys include:
Our firm will be attending the Biotechnology Industry Association (BIO) conference in San Diego, June, 2014.
Keisha Hylton-Rodic, Ph.D. will be moderating an American Bar Association webinar entitled “The Nuts and Bolts of Patents and the Drug Approval Process,” November, 2013.
Our firm is pleased to exhibit at the American Chemical Society national meeting in Indianapolis, September, 2013.
Our firm hosts a delegation of Senior Examiners from the European Patent Office for an educational event entitled “A Conversation with EPO Examiners,” May, 2013.
“Lawyers Offer Predictions for Myriad, Diagnostic Field Based on Supreme Court’s Decision Against Prometheus ”
Genetic Engineering & Biotechnology News
Academic & Pharma Partnerships: Tapping the Ivory Tower for the Next Blockbuster, FiercePharma
“Caveats in Patent Overhaul Could Pose New Challenges for Smaller Biopharmas”
Genetic Engineering & Biotechnology News
“Implementation of European Court Decision to Ban hESC Patents Depends on National Patent Offices”
Genetic Engineering & Biotechnology News
Nevrivy Patent Law Group is exhibiting at the 2011 Entrepreneur Expo, November 14, 2011.
“Asia’s Emerging Markets Catching Up to the U.S. and Europe in Terms of Innovation”Genetic Engineering & Biotechnology News, June 2011
IP Man III, Legal Bisnow (New York) (profiling Sullivan’s IP Law Outline)
IP Lawyers Don’t Need Desks, Legal Bisnow (Washington, D.C.) (profiling Sullivan’s IP Law Outline)
“China gets serious about biotech,” FierceBiotech
“Restoring Science to its Rightful Place in America,” Law360
“Does the U.S. biotech industry deserve a bailout?” FiercePharma and FierceBiotech